Castelion
Castelion Announces $1B Series C Fundraise, Including $800M in Equity
Castelion announced $800M in Series C financing on August 19, 2026. Castelion raised a $1 billion Series C, combining $800 million of equity co-led by JPMorganChase’s Strategic Investment Group, Andreessen Horowitz, and Carlyle-managed funds with $250 million of committed revolving credit, to scale Blackbeard hypersonic missile production.
Round details
The financing includes backing from JPMorganChase Strategic Investment Group, Andreessen Horowitz, Carlyle, Lightspeed Venture Partners, Lavrock Ventures, Altimeter, General Catalyst, Interlagos. The company reported a $13B valuation alongside the transaction.
- Round: Series C
- Capital announced: $800M
- Headquarters: Torrance, CA
How the company plans to use the capital
Castelion said the financing will accelerate the scaled production of Blackbeard, its hypersonic strike missile. The company also said it is accelerating development and test of a much longer-range precision strike weapon and is developing defensive systems.
Why this matters for GTM teams
Castelion’s announcement describes the round as a combination of $800 million in equity financing and $250 million in committed financing for a revolving credit facility, and states that the round values the company at $13 billion.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Castelion Series C announcement.
Company Info
Investors (8)
Share
Related Reports
Infisical Raises $40M Series B for AI Agent Security Infrastructure
Infisical raised a $40 million Series B at a $600 million valuation, led by Elad Gil, to expand security infrastructure for AI agents.
Vera Health Raises $28.5M Series A for Clinical AI Search
Vera Health raised a $28.5 million Series A led by Threshold Ventures to further develop its clinical evidence infrastructure and expand into additional healthcare markets.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free